Risk of Peripheral Neuropathy From Abraxane, Eloxatin, Increased By Certain Risk Factors: Study
A new study appears to identify factors which increase the risk of peripheral neuropathy linked to the use of some cancer drugs.
Tag Archives: Peripheral Neuropathy
-
-
Shingles Vaccine Zostavax Caused Peripheral Neuropathy, Lawsuit Alleges
A Zostavax lawsuit claims the side effects of the shingles vaccine cause peripheral neuropathy; a form of nerve damage.
-
Nerve Damage Caused By Zostavax Shingles Vaccine, Lawsuit Claims
A Zostavax lawsuit claims the shingles vaccine caused a woman to develop chronic nerve pain.
-
Humira, Remicade Side Effects Linked To Increased Peripheral Neuropathy Risk: Study
A new study links drugs like Humira, Enbrel and Remicade to an increased risk of permanent nerve damage.
-
Additional Avelox and Cipro Cases to be Selected for Bellwether Trials
A federal judge has decided that a second round of bellwether trials will take place involving Avelox and Cipro peripheral nerve damage claims.
-
Levaquin Removed From Market Quietly Amid Concerns Over Side Effects of Antibioitic: Report
Production on the antibiotic Levaquin was discontinued in December ahead of new label warnings and a laundry list of recent side effect concerns.
-
Levaquin, Avelox, Cipro Get New FDA Warnings Over Low Blood Sugar, Mental Health Problems
The FDA warns that antibiotics like Levaquin, Cipro and Avelox can cause extremely low blood sugar, resulting in coma, and psychiatric side effects, and is requiring new label warnings.
-
Chemotherapy May Cause Nerve Damage In Some Child Cancer Patients: Study
A new study warns that some chemotherapy drugs may cause a form of nerve damage in child cancer patients.
-
Side Effects of Avelox, Other Antibiotics Still Not Well Understood
A report highlights the problems with getting proper research conducted to uncover the risks of popular antibiotics and their links to potential nerve damage.
-
Avelox Lawsuits Over Nerve Damage Set for Trials to Begin November 2018
A federal judge has scheduled the first Avelox bellwether trial over peripheral neuropathy claims for November 2018.
